T2 Biosystems Inc (NASDAQ: TTOO) is -79.92% lower on its value in year-to-date trading and has touched a low of $1.34 and a high of $8.38 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TTOO stock was last observed hovering at around $1.44 in the last trading session, with the day’s loss setting it -0.18%.
Currently trading at $1.26, the stock is -20.98% and -46.36% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing -12.50% at the moment leaves the stock -67.90% off its SMA200. TTOO registered -77.91% loss for a year compared to 6-month loss of -54.01%. The firm has a 50-day simple moving average (SMA 50) of $2.3489 and a 200-day simple moving average (SMA200) of $3.9253.
The stock witnessed a -37.31% gain in the last 1 month and extending the period to 3 months gives it a -75.25%, and is -7.35% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.80% over the week and 9.90% over the month.
T2 Biosystems Inc (TTOO) has around 113 employees, a market worth around $22.02M and $7.16M in sales. Profit margin for the company is -673.67%. Distance from 52-week low is -5.97% and -84.96% from its 52-week high.
24.0 institutions hold shares in T2 Biosystems Inc (TTOO), with institutional investors hold 78.12% of the company’s shares. The shares outstanding are 17.48M, and float is at 6.02M with Short Float at 5.90%. Institutions hold 74.65% of the Float.
T2 Biosystems Inc (TTOO) Insider Activity
The most recent transaction is an insider sale by Elsbree David B, the company’s Director. SEC filings show that Elsbree David B sold 55 shares of the company’s common stock on Sep 13 ’24 at a price of $2.42 per share for a total of $133.0. Following the sale, the insider now owns 23.0 shares.
